Clinical Trials Directory

Trials / Sponsors / Travere Therapeutics, Inc.

Travere Therapeutics, Inc.

Industry · 14 registered clinical trials — 4 currently recruiting.

StatusTrialPhaseStarted
RecruitingSparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis
Proteinuria, Immunoglobulin A (IgA) Nephropathy, Focal Segmental Glomerulosclerosis
Phase 42025-10-07
Enrolling By InvitationA Phase 3 Long-term Extension Study to Assess the Long-term Safety and Efficacy of Pegtibatinase Treatment in
Homocystinuria
Phase 32024-04-30
Active Not RecruitingA Study to Investigate Efficacy and Safety of Pegtibatinase Compared With Placebo in Participants ≥12 to ≤65 Y
Homocystinuria
Phase 32023-12-28
CompletedA Study to Investigate Safety and Effect of Sparsentan in Combination With SGLT2 Inhibition in Participants Wi
Immunoglobulin A Nephropathy
Phase 22023-05-19
CompletedHumanistic Burden of (FSGS) Focal Segmental Glomerulosclerosis and IgAN (Immunoglobulin A Nephropathy)
Focal Segmental Glomerulosclerosis, Immunoglobulin A Nephropathy
—2022-02-05
RecruitingStudy of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
Focal Segmental Glomerulosclerosis, Minimal Change Disease, Immunoglobulin A Nephropathy
Phase 22021-08-12
CompletedStudy to Evaluate the Pharmacokinetics of Oral Sparsentan Suspension
Healthy Subjects
Phase 12020-06-18
Active Not RecruitingPegtibatinase As an Enzyme Therapy for Patients with Homocystinuria Caused by Cystathionine Beta-Synthase Defi
Homocystinuria
Phase 1 / Phase 22019-01-22
Active Not RecruitingA Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA Nephropathy
Immunoglobulin A Nephropathy
Phase 32018-12-11
CompletedStudy of Sparsentan in Patients With Primary Focal Segmental Glomerulosclerosis (FSGS)
Focal Segmental Glomerulosclerosis
Phase 32018-04-17
TerminatedEfficacy and Safety Study of Fosmetpantotenate (RE-024) in PKAN Participants
Pantothenate Kinase-Associated Neurodegeneration
Phase 32017-07-17
RecruitingNatural History Study of Homocystinuria Caused by Cystathionine Beta-Synthase Deficiency (ACAPPELLA)
Homocystinuria Due to CBS Deficiency
—2017-01-01
CompletedCerebrotendinous Xanthomatosis (CTX) Prevalence Study
Cerebrotendinous Xanthomatosis (CTX)
—2015-09-01
CompletedRandomized, Double-Blind, Safety and Efficacy Study of RE-021 (Sparsentan) in Focal Segmental Glomeruloscleros
Focal Segmental Glomerulosclerosis
Phase 22014-03-01